UK markets close in 4 hours 8 minutes

Hims & Hers Health, Inc. (HIMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
9.69-0.34 (-3.39%)
At close: 04:00PM EDT
9.95 +0.26 (+2.68%)
Pre-market: 08:00AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.03
Open10.00
Bid0.00 x 1000
Ask10.38 x 3200
Day's range9.68 - 10.02
52-week range2.72 - 12.04
Volume2,371,847
Avg. volume2,743,001
Market cap2.02B
Beta (5Y monthly)0.49
PE ratio (TTM)N/A
EPS (TTM)-0.31
Earnings date08 May 2023 - 12 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est11.95
  • Business Wire

    Hims & Hers Welcomes Five New Experts to Its Medical Advisory Board

    SAN FRANCISCO, March 16, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is adding five new members to its Medical Advisory Board. The group of specialists advises the company as it works to create access to safe, high-quality, personalized care and treatment. These new advisors represent a diverse group of medical experts specializing in medicine related to obesity, menopause, and cardiometabolic health.

  • Business Wire

    Hims & Hers Announces New Anti-Dandruff Shampoo for Hims Customers

    SAN FRANCISCO, March 15, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is today announcing Hims Dandruff Detox, a unique shampoo formulated with doctors that both fights dandruff and supports scalp health. This powerful and gently-cleansing formula was developed with doctors to be vegan, cruelty-free and free of parabens, phthalates, sulfates and dyes.

  • Business Wire

    Hims & Hers Appoints Senior Vice President of Mental Health Advancing Efforts to Provide the Highest Quality of Innovative Care for Anxiety and Depression

    SAN FRANCISCO, March 14, 2023--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform on a mission to help the world feel great through the power of better health, today announces a key leadership appointment, naming psychiatry and behavioral sciences industry veteran Dr. Daniel Lieberman, M.D., as the company’s Senior Vice President of Mental Health.